Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Royal Orchid Resort & Convention Centre

Jul 10, 2026 8:00 AM - Jul 11, 2026 6:00 PM

Jakkur Flying Club, Near Bellary Road, Allalasandra, Yelahanka, Bengaluru 560065, KA, India

DIA Medical Writing & Scientific Communication Conference - 2026

Redefining Medical Writing Practices: Global Insights, Local Excellence, and Future Frontiers

Session 1: The Future of Medical Writing in India: Evolving GCC-CRO-Solution Providers Operating Models and Strategic Partnerships

Session Chair(s)

Sam Thomarayil Mathew, Ph.D

Sam Thomarayil Mathew, Ph.D

Director, Medical Delivery, AstraZeneca India Pvt Ltd, India

Sonia  Philipose, Ph.D

Sonia Philipose, Ph.D

Medical Communications and Content Solutions Lead- Vaccines, Pfizer Inc, India

Session Overview: Medical writing in India sits at an interesting crossroads in 2026. Pharma Global Capability Centers (GCCs) have expanded their remit and capability across the regulatory and medical communications spectrum. Clinical Research Organizations (CROs) and agency medical writing teams offer complementary strengths, therapeutic expertise, specialist submission know how, and scalable capacity that supports pharmaceutical programs. Historically, these models have operated in parallel. This session examines what it would take to align them more closely, focusing on ways of working, ownership of quality, ethical standards, AI governance, and talent engagement across both organizations. The future of pharma medical writing in India rests on a balanced co-existence model that leverages the distinct strengths of GCCs, CROs, and agencies. This session brings together leaders across these organizations to explore the collaboration framework- and invites professionals across the field to share their perspectives in a conversation that will shape how this profession evolves in India

Speaker(s)

Akshata  Rao

Akshata Rao

Director- Global Medical Writing, India, Merck Group, India

Beyond cost arbitrage: How Medical Writing GCCs are delivering scientific and strategic value for Global Pharma

Swapnil  Puranik

Swapnil Puranik

Head of Strategy - Enterprise Medical, Indegene, India

Roopa  Basrur

Roopa Basrur

Vice President, Global Safety Medical Writing Services, Parexel International, India

Panel Discussion

Shivanand  Jigajinni

Shivanand Jigajinni

Director- Head of India MW Operations. Global Medical Writing - DSSM, IQVIA, India

Shwetha  Shetty

Shwetha Shetty

Senior Director, HEOR, Clinical Development, Clinical Capabilities, Eli Lilly, India

Sheetal  Pradhan

Sheetal Pradhan

Director – Head, GCC Publications, Global Publications, GSK, India

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.